Literature DB >> 16720014

SUMO: a ubiquitin-like protein modifier.

Mary B Kroetz1.   

Abstract

SUMO (Small Ubiquitin-related Modifier) is a small protein that covalently attaches to a lysine residue of another protein in a reversible fashion. SUMO attachment to its substrate proteins causes changes in the localization, activity, or binding partners of the substrate. SUMO has been shown to play a role in a multitude of processes; these include chromosome segregation, cell cycle progression, and DNA damage recovery. Defects in the SUMO pathway have been demonstrated to affect tumorigenesis and the inflammatory response as well as other human diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16720014      PMCID: PMC2259148     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  16 in total

1.  HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.

Authors:  Phillip R Heaton; Adeline F Deyrieux; Xue-Lin Bian; Van G Wilson
Journal:  Virus Res       Date:  2011-04-12       Impact factor: 3.303

2.  Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.

Authors:  Gretchen L Bentz; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

3.  LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.

Authors:  Gretchen L Bentz; Charles Randall Moss; Christopher B Whitehurst; Cary A Moody; Joseph S Pagano
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

4.  Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation.

Authors:  Qian Liu; Jing Li; Joseph Khoury; Sean P Colgan; Juan C Ibla
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

5.  SUMO-1 possesses DNA binding activity.

Authors:  Sebastian Eilebrecht; Caroline Smet-Nocca; Jean-Michel Wieruszeski; Arndt Benecke
Journal:  BMC Res Notes       Date:  2010-05-26

6.  Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation.

Authors:  Gretchen L Bentz; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

7.  Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.

Authors:  Peter Garcia; Abigail Harrod; Shruti Jha; Jessica Jenkins; Alex Barnhill; Holden Lee; Merritt Thompson; Jordan Pringle Williams; James Barefield; Ashton Mckinnon; Persia Suarez; Ananya Shah; Angela J Lowrey; Gretchen L Bentz
Journal:  Antiviral Res       Date:  2021-02-10       Impact factor: 5.970

8.  SUMOylation of HNF4α regulates protein stability and hepatocyte function.

Authors:  Wenli Zhou; Zara Hannoun; Ellis Jaffray; Claire N Medine; James R Black; Sebastian Greenhough; Liang Zhu; James A Ross; Stuart Forbes; Ian Wilmut; John P Iredale; Ronald T Hay; David C Hay
Journal:  J Cell Sci       Date:  2012-04-14       Impact factor: 5.285

9.  SUMOhunt: Combining Spatial Staging between Lysine and SUMO with Random Forests to Predict SUMOylation.

Authors:  Amna Ijaz
Journal:  ISRN Bioinform       Date:  2013-06-17

10.  A novel method for high accuracy sumoylation site prediction from protein sequences.

Authors:  Jialin Xu; Yun He; Boqin Qiang; Jiangang Yuan; Xiaozhong Peng; Xian-Ming Pan
Journal:  BMC Bioinformatics       Date:  2008-01-08       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.